Claudia Calcagno

Dynamic contrast enhanced (DCE) magnetic resonance imaging (MRI) of atherosclerotic plaque angiogenesis.

SHILO, a novel dual imaging approach for simultaneous HI-/LOw temporal (Low-/Hi-spatial) resolution imaging for vascular dynamic contrast enhanced cardiovascular magnetic resonance: numerical simulations and feasibility in the carotid arteries.

Attenuation correction for flexible magnetic resonance coils in combined magnetic resonance/positron emission tomography imaging.

Registration of dynamic contrast-enhanced MRI of the common carotid artery using a fixed-frame template-based squared-difference method.

Probing nanoparticle translocation across the permeable endothelium in experimental atherosclerosis.

DCE-MRI of the liver: effect of linear and nonlinear conversions on hepatic perfusion quantification and reproducibility.

Alternatively spliced tissue factor promotes plaque angiogenesis through the activation of hypoxia-inducible factor-1α and vascular endothelial growth factor signaling.

DCE-MRI of the liver: reconstruction of the arterial input function using a low dose pre-bolus contrast injection.

Atherosclerotic plaque targeting mechanism of long-circulating nanoparticles established by multimodal imaging.

Pharmaceutical development and preclinical evaluation of a GMP-grade anti-inflammatory nanotherapy.

Prednisolone-containing liposomes accumulate in human atherosclerotic macrophages upon intravenous administration.

Simultaneous carotid PET/MR: feasibility and improvement of magnetic resonance-based attenuation correction.

Markerless attenuation correction for carotid MRI surface receiver coils in combined PET/MR imaging.

Quantitative carotid PET/MR imaging: clinical evaluation of MR-Attenuation correction versus CT-Attenuation correction in (18)F-FDG PET/MR emission data and comparison to PET/CT.

Inhibiting macrophage proliferation suppresses atherosclerotic plaque inflammation.

Three-dimensional dynamic contrast-enhanced MRI for the accurate, extensive quantification of microvascular permeability in atherosclerotic plaques.

Imaging Macrophage and Hematopoietic Progenitor Proliferation in Atherosclerosis.

Systems Biology and Noninvasive Imaging of Atherosclerosis.

In Vivo PET Imaging of HDL in Multiple Atherosclerosis Models.

Immune cell screening of a nanoparticle library improves atherosclerosis therapy.

Imaging the Permeable Endothelium: Predicting Plaque Rupture in Atherosclerotic Rabbits.

Relation between resting amygdalar activity and cardiovascular events: a longitudinal and cohort study.

Polyglucose nanoparticles with renal elimination and macrophage avidity facilitate PET imaging in ischaemic heart disease.

Feasibility of imaging superficial palmar arch using micro-ultrasound, 7T and 3T magnetic resonance imaging.

Investigating the Cellular Specificity in Tumors of a Surface-Converting Nanoparticle by Multimodal Imaging.

Intraplaque and Cellular Distribution of Dextran-Coated Iron Oxide Fluorescently Labeled Nanoparticles: Insights Into Atherothrombosis and Plaque Rupture.

Plaque microvascularization and permeability: Key players in atherogenesis and plaque rupture.

Vessel wall characterization using quantitative MRI: what's in a number?

PET/MR Imaging of Malondialdehyde-Acetaldehyde Epitopes With a Human Antibody Detects Clinically Relevant Atherothrombosis.

Combined PET/DCE-MRI in a Rabbit Model of Atherosclerosis: Integrated Quantification of Plaque Inflammation, Permeability, and Burden During Treatment With a Leukotriene A4 Hydrolase Inhibitor.

Development and Multiparametric Evaluation of Experimental Atherosclerosis in Rabbits.

Nanobody-Facilitated Multiparametric PET/MRI Phenotyping of Atherosclerosis.

Monocyte and Macrophage Dynamics in the Cardiovascular System: JACC Macrophage in CVD Series (Part 3).

Inhibiting Inflammation with Myeloid Cell-Specific Nanobiologics Promotes Organ Transplant Acceptance.

Hybrid PET/MR Kernelised Expectation Maximisation Reconstruction for Improved Image-Derived Estimation of the Input Function from the Aorta of Rabbits.

Sodium Fluoride PET and Aortic Bioprosthetic Valve Degeneration: Implications for Patient Diagnosis, Management, and Treatment.

Emerging Magnetic Resonance Imaging Techniques for Atherosclerosis Imaging.

Efficacy and safety assessment of a TRAF6-targeted nanoimmunotherapy in atherosclerotic mice and non-human primates.

Author Correction: Efficacy and safety assessment of a TRAF6-targeted nanoimmunotherapy in atherosclerotic mice and non-human primates.

Multimodal Positron Emission Tomography Imaging to Quantify Uptake of Zr-Labeled Liposomes in the Atherosclerotic Vessel Wall.

Advances in Therapies and Imaging for Systemic Vasculitis.

Imaging-assisted nanoimmunotherapy for atherosclerosis in multiple species.

An iterative sparse deconvolution method for simultaneous multicolor F-MRI of multiple contrast agents.

Hybrid PET- and MR-driven attenuation correction for enhanced F-NaF and F-FDG quantification in cardiovascular PET/MR imaging.

Clinical imaging of cardiovascular inflammation.

Whole-Body Atherosclerosis Imaging by Positron Emission Tomography/Magnetic Resonance Imaging: From Mice to Nonhuman Primates.

Hybrid FDG-PET/MR or FDG-PET/CT to Detect Disease Activity in Patients With Persisting Arrhythmias After Myocarditis.

Probing myeloid cell dynamics in ischaemic heart disease by nanotracer hot-spot imaging.

Artificial intelligence-enabled rapid diagnosis of patients with COVID-19.

Imaging Cardiovascular and Lung Macrophages With the Positron Emission Tomography Sensor Cu-Macrin in Mice, Rabbits, and Pigs.

Trained Immunity-Promoting Nanobiologic Therapy Suppresses Tumor Growth and Potentiates Checkpoint Inhibition.

Multimodal imaging of bacterial-host interface in mice and piglets with endocarditis.

Ultra-high resolution, 3-dimensional magnetic resonance imaging of the atherosclerotic vessel wall at clinical 7T.

USPIO-Enhanced CMR of Myocardial Inflammation: What Are We Imaging?

A modular approach toward producing nanotherapeutics targeting the innate immune system.

Imaging-guided nanomedicine development.